← Back to all trials
Enrolling By Invitation
NCT06254677
Western Sydney Kidney Injury Biopsy Study
Conditions: Kidney Injury
Sex: All
Ages: 18 Years – 80 Years
Enrollment: 1000
Sponsor: Western Sydney Local Health District
Location: Westmead Hospital Westmead
Summary
The investigators aim to develop a clinically validated, histological acute tubular injury (ATI) scoring system to help improve diagnostic precision and predict clinical outcomes following ATI.
To use an unbiased, data-driven approach, correlating pathological features (including digital pathology), key signatures using spatial technologies (transcriptomics or proteinomics) with relevant clinical outcomes. Spatial technologies (including spatial transcriptomics and spatial proteinomics) allow the use of 'precision pathology' to study the critical link between molecular characteristics to histological structure.
Eligibility Criteria
Inclusion Criteria:
1. Had a kidney biopsy (native kidney or transplant kidney included) after year 2000
2. Kidney biopsy sample sent to Westmead Hospital for clinical interpretation
Exclusion Criteria:
1. Patients who have never had a kidney biopsy performed
2. Biopsy sample not available at Westmead Hospital
3. No information on kidney function (serum creatinine or eGFR)
Source: ClinicalTrials.gov (NCT06254677). StuddyBuddy aggregates publicly available trial information.